MSFHR funds 11 BC innovators in first Innovation to Commercialization awards

August 25, 2017

The Michael Smith Foundation for Health Research has announced 11 award recipients in the first Innovation to Commercialization (I2C) competition. These awards will help BC health researchers bridge the gap between discovery and practical application to improve health outcomes in BC.

The 11 award recipients, selected through MSFHR's rigorous peer review process including national experts from academia and industry, are working on products and technologies that range from a liquid skin substitute for wound healing, to a treatment regimen to enhance the effectiveness of cancer radiotherapy, and an organ preservation solution to better protect donor organs in preparation for transplant.

More information and a full list of I2C award recipients is available on the MSFHR website.